GDF15 is a dynamic biomarker of the integrated stress response in the central nervous system.

Bibliographic Details
Title: GDF15 is a dynamic biomarker of the integrated stress response in the central nervous system.
Authors: Asundi, Jyoti, Zhang, Chunlian, Donnelly‐Roberts, Diana, Solorio, Josè Zavala, Challagundla, Malleswari, Connelly, Caitlin, Boch, Christina, Chen, Jun, Richter, Mario, Maneshi, Mohammad Mehdi, Swensen, Andrew M., Lebon, Lauren, Schiffmann, Raphael, Sanyal, Subhabrata, Sidrauski, Carmela, Kolumam, Ganesh, Baruch, Amos
Source: CNS Neuroscience & Therapeutics; Feb2024, Vol. 30 Issue 2, p1-12, 12p
Subject Terms: CENTRAL nervous system, GROWTH differentiation factors, RETINAL ganglion cells, LEUKOENCEPHALOPATHIES, BIOMARKERS
Abstract: Aim: Characterize Growth Differentiation Factor 15 (GDF15) as a secreted biomarker of the integrated stress response (ISR) within the central nervous system (CNS). Methods: We determined GDF15 levels utilizing in vitro and in vivo neuronal systems wherein the ISR was activated. Primarily, we used the murine model of vanishing white matter disease (VWMD), a neurological disease driven by persistent ISR in the CNS, to establish a link between levels of GDF15 in the cerebrospinal fluid (CSF) and ISR gene expression signature in the CNS. GDF15 was also determined in the CSF of VWM patients. Results: GDF15 expression was increased concomitant to ISR activation in stress‐induced primary astrocytes as well as in retinal ganglion cells following optic nerve crush, while treatment with 2Bact, a specific eIF2B activator, suppressed both the ISR and GDF15. In the VWMD model, CSF GDF15 levels corresponded with the magnitude of the ISR and were reduced by 2BAct. In VWM patients, mean CSF GDF15 was elevated >20‐fold as compared to healthy controls, whereas plasma GDF15 was undifferentiated. Conclusions: These data suggest that CSF GDF15 is a dynamic marker of ISR activation in the CNS and may serve as a pharmacodynamic biomarker for ISR‐modulating therapies. [ABSTRACT FROM AUTHOR]
Copyright of CNS Neuroscience & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Full text is not displayed to guests.
More Details
ISSN:17555930
DOI:10.1111/cns.14600
Published in:CNS Neuroscience & Therapeutics
Language:English